COSMOS Pharmaceutical Corporation【JP:3349】Cash flow
Market cap
¥611.4B
P/E ratio
19.5x
| 2014/05 | 2015/05 | 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | |
| Depreciation & amortization | 5,604 | 7,342 | 9,588 | 10,710 | 11,885 | 12,958 | 13,562 | 13,785 | 15,110 | 17,368 | 19,924 | 22,229 |
| Cash from operations | 25,962 | 19,454 | 30,986 | 36,938 | 32,586 | 34,379 | 65,461 | 27,875 | 32,194 | 54,434 | 55,175 | 52,467 |
| Capital expenditures | -20,144 | -29,865 | -31,092 | -28,667 | -29,451 | -29,040 | -25,948 | -26,064 | -43,497 | -46,636 | -55,810 | -53,326 |
| Cash from investing | -20,118 | -29,272 | -28,550 | -28,404 | -30,458 | -30,042 | -26,956 | -19,381 | -43,717 | -49,113 | -57,329 | -55,448 |
| Payments for dividends | -1,088 | -1,138 | -1,237 | -1,385 | -1,781 | -1,781 | -2,077 | -2,277 | -3,266 | -3,266 | -4,659 | -4,959 |
| Repurchases of common stock | -1 | - | - | - | - | - | - | - | -2 | - | - | -2 |
| Proceeds from issuance of term debt, net | 3,000 | 12,000 | 14,000 | - | - | - | - | - | 300 | 10,000 | 18,400 | 20,000 |
| Repayments of term debt | -1,486 | -2,515 | -5,006 | -4,951 | -4,486 | -3,199 | -1,486 | -1,486 | -1,486 | -1,628 | -3,193 | -5,082 |
| Cash from financing | -452 | 7,151 | 6,211 | -8,088 | -8,188 | -6,982 | -5,405 | -5,507 | -6,222 | 3,245 | 8,527 | 7,717 |